BR0115483A - Preparação de pantoprazol seco por congelação e injeção de pantoprazol - Google Patents

Preparação de pantoprazol seco por congelação e injeção de pantoprazol

Info

Publication number
BR0115483A
BR0115483A BR0115483-4A BR0115483A BR0115483A BR 0115483 A BR0115483 A BR 0115483A BR 0115483 A BR0115483 A BR 0115483A BR 0115483 A BR0115483 A BR 0115483A
Authority
BR
Brazil
Prior art keywords
pantoprazole
injection
preparation
freeze
dried
Prior art date
Application number
BR0115483-4A
Other languages
English (en)
Other versions
BRPI0115483B8 (pt
BRPI0115483B1 (pt
Inventor
Rango Dietrich
Rudolf Linder
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0115483(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BR0115483A publication Critical patent/BR0115483A/pt
Publication of BRPI0115483B1 publication Critical patent/BRPI0115483B1/pt
Publication of BRPI0115483B8 publication Critical patent/BRPI0115483B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PREPARAçãO DE PANTOPRAZOL SECO POR CONGELAçãO E INJEçãO DE PANTOPRAZOL". A presente invenção refere-se a preparações de pantoprazol liofilizado que são obteníveis através de secagem por congelação de uma solução aquosa de pantoprazol, ácido etilenodiamina tetracético e/ou um sal adequado do mesmo, e hidróxido de sódio e/ou carbonato de sódio. As preparações apresentam propriedades vantajosas quando reconstituídas para injeção.
BRPI0115483A 2000-11-22 2001-11-17 preparação de pantoprazol seco por congelação e injeção de pantoprazol BRPI0115483B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22
PCT/EP2001/013296 WO2002041919A1 (en) 2000-11-22 2001-11-17 Freeze-dried pantoprazole preparation and pantoprazole injection

Publications (3)

Publication Number Publication Date
BR0115483A true BR0115483A (pt) 2003-10-21
BRPI0115483B1 BRPI0115483B1 (pt) 2017-05-09
BRPI0115483B8 BRPI0115483B8 (pt) 2021-05-25

Family

ID=8170452

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0115483A BRPI0115483B8 (pt) 2000-11-22 2001-11-17 preparação de pantoprazol seco por congelação e injeção de pantoprazol

Country Status (40)

Country Link
US (3) US6780881B2 (pt)
EP (2) EP1762249A3 (pt)
JP (1) JP4886158B2 (pt)
KR (2) KR100910606B1 (pt)
CN (1) CN1250292C (pt)
AR (2) AR034277A1 (pt)
AT (1) ATE381946T1 (pt)
AU (2) AU2002216042B2 (pt)
BG (1) BG66329B1 (pt)
BR (1) BRPI0115483B8 (pt)
CA (2) CA2541946A1 (pt)
CY (1) CY1107896T1 (pt)
CZ (1) CZ304348B6 (pt)
DE (1) DE60132108T2 (pt)
DK (1) DK1339430T3 (pt)
EA (1) EA007602B1 (pt)
EC (1) ECSP034613A (pt)
EE (1) EE05236B1 (pt)
ES (1) ES2298295T3 (pt)
GE (1) GEP20053461B (pt)
HK (1) HK1060848A1 (pt)
HR (1) HRP20030410B1 (pt)
HU (1) HUP0303278A3 (pt)
IL (2) IL155601A0 (pt)
IS (1) IS2971B (pt)
ME (1) ME00556A (pt)
MX (1) MXPA03004548A (pt)
MY (1) MY137726A (pt)
NO (1) NO332937B1 (pt)
NZ (1) NZ525911A (pt)
PE (1) PE20020582A1 (pt)
PL (1) PL201188B1 (pt)
PT (1) PT1339430E (pt)
RS (1) RS52024B (pt)
SI (1) SI1339430T1 (pt)
SK (1) SK287993B6 (pt)
TW (1) TWI284041B (pt)
UA (1) UA80961C2 (pt)
WO (1) WO2002041919A1 (pt)
ZA (1) ZA200303593B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
AU2003267763A1 (en) * 2002-10-25 2004-05-13 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
WO2004099183A1 (en) * 2003-05-06 2004-11-18 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
WO2009001163A1 (en) * 2006-06-01 2008-12-31 Combino Pharm, S.L. Lyophilized preparations of pantoprazole sodium for injection
BRPI0715113A2 (pt) 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
NZ703528A (en) * 2012-06-27 2016-08-26 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
US5223515A (en) 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
KR100258423B1 (ko) 1992-07-28 2000-07-01 클래스 빌헬름슨 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트
EP0695123A4 (en) 1993-04-27 1996-09-11 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING GASTRICAL FAULTS USING OPTICALLY PURE PANTOPRAZOLS
DE4324014C2 (de) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (pt) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
ES2268800T3 (es) 1997-10-14 2007-03-16 Eisai Co., Ltd. Formulacion farmaceutica que comprende glicina como estabilizador.
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Also Published As

Publication number Publication date
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23
ME00556B (me) 2011-12-20
EA007602B1 (ru) 2006-12-29
RS52024B (sr) 2012-04-30
HRP20030410B1 (en) 2011-02-28
CZ20031416A3 (cs) 2003-09-17
AR092374A2 (es) 2015-04-15
EP1762249A2 (en) 2007-03-14
ATE381946T1 (de) 2008-01-15
SI1339430T1 (sl) 2008-06-30
US20030003058A1 (en) 2003-01-02
IS6820A (is) 2003-05-19
EP1762249A3 (en) 2014-05-14
BG66329B1 (bg) 2013-06-28
GEP20053461B (en) 2005-02-25
HUP0303278A2 (hu) 2004-01-28
SK287993B6 (sk) 2012-09-03
US8754108B2 (en) 2014-06-17
US20040220228A1 (en) 2004-11-04
CZ304348B6 (cs) 2014-03-19
HK1060848A1 (en) 2004-08-27
IL155601A (en) 2008-12-29
DE60132108T2 (de) 2008-12-11
KR100910607B1 (ko) 2009-08-04
BRPI0115483B8 (pt) 2021-05-25
YU37703A (sh) 2006-05-25
IS2971B (is) 2017-05-15
AU2002216042B2 (en) 2006-08-03
MY137726A (en) 2009-03-31
AR034277A1 (es) 2004-02-18
PL361118A1 (en) 2004-09-20
US6780881B2 (en) 2004-08-24
EA200300501A1 (ru) 2003-12-25
IL155601A0 (en) 2003-11-23
EP1339430B1 (en) 2007-12-26
CN1250292C (zh) 2006-04-12
TWI284041B (en) 2007-07-21
DE60132108D1 (de) 2008-02-07
MXPA03004548A (es) 2003-09-10
NO20032303L (no) 2003-05-21
EE200300182A (et) 2003-06-16
ES2298295T3 (es) 2008-05-16
US20090093522A1 (en) 2009-04-09
PT1339430E (pt) 2008-03-27
PE20020582A1 (es) 2002-07-06
KR100910606B1 (ko) 2009-08-04
CA2541946A1 (en) 2002-05-30
CN1476335A (zh) 2004-02-18
EE05236B1 (et) 2009-12-15
EP1339430A1 (en) 2003-09-03
SK6062003A3 (en) 2003-10-07
HUP0303278A3 (en) 2007-08-28
DK1339430T3 (da) 2008-05-13
JP4886158B2 (ja) 2012-02-29
NO332937B1 (no) 2013-02-04
ME00556A (en) 2011-12-20
ECSP034613A (es) 2003-08-29
PL201188B1 (pl) 2009-03-31
JP2004513970A (ja) 2004-05-13
CA2428870A1 (en) 2002-05-30
CY1107896T1 (el) 2013-09-04
ZA200303593B (en) 2004-04-23
WO2002041919A1 (en) 2002-05-30
KR20080003010A (ko) 2008-01-04
UA80961C2 (en) 2007-11-26
US7351723B2 (en) 2008-04-01
BRPI0115483B1 (pt) 2017-05-09
NO20032303D0 (no) 2003-05-21
NZ525911A (en) 2004-11-26
HRP20030410A2 (en) 2005-04-30
KR20030055308A (ko) 2003-07-02
BG107828A (bg) 2004-07-30

Similar Documents

Publication Publication Date Title
BR0115483A (pt) Preparação de pantoprazol seco por congelação e injeção de pantoprazol
BRPI0409450A (pt) composições que contêm peperacilina e tazobactamo, úteis para injeção
KR950702419A (ko) 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트(injection and injection kit containing omeprazole and its analogs)
PE20001027A1 (es) Una composicion farmaceutica de un polipeptido y un compuesto anfifilico en forma de un complejo ionico y el uso de la misma
DK0758018T3 (da) Saltstabiliserede enzympræparater
BR9906903A (pt) Composição com liberação sustentada, processos para produzir a mesma, para suprimir a brusca liberação inicial da susbtância bioativa de uma composição com liberação sustentada e para aumentar a eficiência da inclusão da substância bioativa em uma composição com liberação sustentada, produto farmacêutico, agente para prevenir ou tratar câncer prostático, hipertrofia prostática, endometriose, histeromioma, metrofibroma, puberdade precoce, dismenorréia, ou câncer do seio, ou um contraceptivo, e, composto
BR0116691A (pt) Produto antitranspirante, métodos cosméticos para atingir antitranspiração e/ou benefìcio desodorante e método para a fabricação de uma composição antitranspirante
EP0191133A3 (en) Stable salts of sam with polyanions
PT877602E (pt) Processo para o fabrico de composicoes de surfactantes pulmonares em po
BR9908929A (pt) Desenvolvimento de filhote normal de ovócitos injetados com espermatozóides secos por congelamento
BRPI0503397A (pt) composição de coloração, processo de coloração e uso de uma composição
BRPI0413967A (pt) polìmero solúvel em água, processo para preparar um polìmero solúvel em água, composição e solução aquosa
BRPI0509401A (pt) composições e métodos para branqueamento, mineralização e/ou fluoração de tecidos calcificados
BRPI9805021A (pt) processo para estabilizar proteínas em um processo de congelamento e liofilização ou durante armazenagem em baixas temperaturas, forma de armazenagem e composição farmacêutica.
MY117606A (en) Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
MX9401211A (es) Composicion y procedimiento para combatir la aglomeracion de abonos.
GR3026209T3 (en) Compositions containing quinolone antibiotics and sulfonate of polystyrol.
DE60009926D1 (de) Stabilisierung von gefriergetrocknetem kuchen
PE22995A1 (es) Composicion de tiotepa liofilizada estable
KR840002657A (ko) 인터페론 조성물의 제조방법
WO2004009688A3 (de) Verwendung von festen pigmentzubereitungen zur einfärbung von kunststoffen
EP1161945A3 (en) Pharmaceutical composition based on proline, glycine and lysine used in the therapy for the healing of tendon lesions and open wounds
BR112022007397A2 (pt) Composição excipiente coprocessada efervescente estável e processo para sua preparação
NO960707L (no) Höyvisköse, sulfonsyregruppeholdige kondensasjonsprodukter på basis av amino-s-triazinre
ATE307594T1 (de) Anaesthetische zusammensetzungen enthaltend alfaxalon

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE) , NYCOMED GERMA

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/11/2021